Rare but serious risks include pancreatitis, thyroid C-cell concerns (primarily animal data), and retinopathy in diabetic patients
Mechanistically, they activate Nrf2 and block ubiquitin-mediated GPX4 degradation, thereby inhibiting ferroptosis and alleviating cartilage erosion, pain, and gait abnormalities in DMM-induced OA (192)
These variations directly impact absorption rates, half-lives, and bioavailability, ultimately influencing dosing regimens and the duration of therapeutic action: 2.6
Appel, N., Pietschmann, T
MOTS-c accelerates bone fracture healing by stimulating osteogenesis of bone marrow mesenchymal stem cells via positively regulating FOXF1 to activate the TGF- pathway
This means treatments are more targeted, potentially leading to better and faster results